EyePoint Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
EYPT EyePoint Pharmaceuticals Inc
BGFV Big 5 Sporting Goods Corp
LXFR Luxfer Holdings PLC
SHOO Steven Madden Ltd
FISV Fiserv Inc
UFI Unifi Inc
SSTK Shutterstock Inc
CSGP CoStar Group Inc
OBELF Obsidian Energy Ltd
RCKY Rocky Brands Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Eyepoint Pharmaceuticals, Inc., formerly pSivida Corp, develops drug delivery products primarily for the treatment of chronic eye diseases. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase III clinical trials; ILUVIEN for diabetic macular edema (DME), its lead licensed product that is sold in the United States and European Union (EU) countries, and Retisert. Medidur is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye (posterior segment uveitis). ILUVIEN is an injectable micro-insert that provides treatment of DME from a single injection. Retisert is an implant that provides treatment of posterior segment uveitis. Its product development program is focused on utilizing its two technology platforms, Durasert and Tethadur, to deliver drugs and biologics to treat chronic diseases.

Closing Price
$0.4001
Day's Change
-0.0104 (-2.53%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.4196
Day's Low
0.40
Volume
(Light)
Volume:
875,637

10-day average volume:
1,949,006
875,637
  • Prev Close
    0.4105
  • Today's Open
    0.4127
  • Day's Range
    0.40-0.4196
  • Avg Vol (10-day)
    1.9M
  • Last (time)
    4:00p ET 10/27/20
  • Last (size)
    100
  • 52-Wk Range
    0.40 - 2.53
    LowHigh
  • (11/04/19 - 10/27/20)
    0.02%
  • 95.9%
  • Market Cap
    53.5M
  • Shares Outstanding
    133.8M
  • -0.46
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 45.30
  • (% of float 10/15/20)
    1.65

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.